Skip to content
FIND A BIOALPS ACTOR
Zeta

ZETA | A new subsidiary in Switzerland (Visp, VS)

22.01.2021
Share this article

Switzerland is the Mecca of the pharmaceutical industry

 

ZETA, the engineering specialist for the pharmaceutical and biotech industries, manages 12 subsidiaries in seven countries worldwide. The latest subsidiary has recently been opened in Visp, a center of the Swiss pharmaceutical industry, with the aim of working even more closely with the global players and medium-sized companies in the pharmaceutical industry in western Switzerland.

Switzerland may only account for one tenth of a percent of the world’s population, but the Alpine republic is nonetheless home to the headquarters of two of the six largest global pharmaceutical groups. Switzerland is the mecca of the pharmaceutical industry and is regarded as the driver of innovation for the international market. This is precisely why engineering specialist ZETA cooperates closely with Swiss pharmaceutical companies.

 

Following up on customer requests – quickly and with great expertise

In order to take this successful cooperation to the next level, ZETA has now established a new subsidiary in Visp. From project management and planning, to engineering, digitisation, automation and maintenance of pharmaceutical and bio-engineering process plants and the related HVAC and cleanroom planning – ZETA is well-established as a one-stop-shop on the international scene. Its services are appreciated not only by the big players in the industry, but also by start-up companies and mid-sized pharmaceutical enterprises. While major contracts are processed at the ZETA headquarters, the subsidiary in Visp will mainly profit from the close vicinity to its customers and focus on personal support.

 

ZETA & Lonza – a shared success story

With the new subsidiary, ZETA can now provide even more targeted support to its customer of many years, Lonza, at the world’s largest production site in Visp in the Swiss canton of Valais. The cooperation between ZETA and Lonza has been characterised by particularly innovative projects. One example is an ultra-fast-track project that ZETA implemented within the framework of Lonza’s lighthouse project IBEX Solutions. The Austrian engineering experts were in charge of detail engineering, design and assembly of a single-use USP and DSP for a mammalian-cell line with more than 29 utility stations and supply lines with a total length of more than 6.2 kilometers in this project.

 

About ZETA GmbH

The ZETA Group specialises in the planning, design, development, production, automation, digitisation, (preventive) maintenance and repair of customer-specific processes for aseptic applications. It employs around 800 people. Highly complex, customised plants produce biopharmaceutical active ingredients such as anticancer agents, insulin, vaccines and IV therapies. ZETA supports its customers along the entire development and production process with mature and sophisticated solutions from laboratory to industrial production of active ingredients.

 

Press Release